Several brokerages have updated their recommendations and price targets on shares of Alpha Tau Medical (NASDAQ: DRTS) in the last few weeks:7/23/2026 – Alpha Tau Medical had its “buy” rating reaffirmed by Benchmark Co..7/22/2026 – Alpha Tau Medical had its “buy” rating reaffirmed by HC Wainwright. 7/17/2026 – Alpha Tau Medical had its “sell (d-)” rating reaffirmed by Weiss Ratings. Get Alpha Tau Medical Ltd alerts:Alpha Tau Medical Ltd. is a medical technology company headquartered in Ness Ziona, Israel, focused on developing targeted alpha-radiation therapies for the treatment of solid tumors. By harnessing the potent cytotoxic effects of alpha radiation, Alpha Tau Medical aims to offer a novel approach to brachytherapy that can potentially overcome radioresistance and spare surrounding healthy tissue. Featured StoriesReceive News & Ratings for Alpha Tau Medical Ltd Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alpha Tau Medical Ltd and related companies with MarketBeat.com's FREE daily email newsletter.